Two-a-Day Pfizer Obesity Pill Nixed
An experimental treatment for obesity meant to be taken twice a day is heading back to...
Read MoreAn experimental treatment for obesity meant to be taken twice a day is heading back to...
Read MoreApparently, OpenAI’s loss is Microsoft’s gain. As the tech titan announced that it...
Read MoreInvestors can’t seem to get enough of ride-hailing pioneer Uber. So much, in fact, that the...
Read MoreFor the first time since July of this year, the yuan went over its daily reference exchange rate....
Read MoreThanks to new contracts recently signed between the United Auto Workers (UAW) and Detroit’s...
Read MoreGet A Free Investor Package